Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...

Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...

Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

A company that hardly needs an introduction is Eli Lilly, but what has it been up to lately, and what’s its pipeline strategy? Over the past year, Lilly has mixed headline-grabbing science with ...

Learn why rare diseases are more common in some communities due to cousin marriages and founder effects in population ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...